encainide has been researched along with Coronary Disease in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (57.14) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hellestrand, KJ | 1 |
| Bates, HR; Cohen, AI; DiBianco, R; Fletcher, RD; Gottdiener, JS; Katz, RJ; Sauerbrunn, B; Singh, SN | 1 |
| Bassett, AL; Ezrin, AM; Gelband, H; Myerburg, RJ; Wong, SS | 1 |
| Anderson, JL; Karagounis, LA; Pratt, CM; Waldo, AL | 1 |
| Estes, NA; Manolis, AS; Weintraub, AR | 1 |
| Campbell, TJ; Hemsworth, PD | 1 |
| Lampert, S; Lown, B; Podrid, PJ; Slater, W | 1 |
1 review(s) available for encainide and Coronary Disease
| Article | Year |
|---|---|
Comparison of the efficacy of newly developed antiarrhythmic drugs in the treatment of ventricular tachyarrhythmias.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzeneacetamides; Coronary Disease; Encainide; Flecainide; Heart Ventricles; Humans; Lidocaine; Mexiletine; Myocardial Infarction; Piperidines; Tachycardia; Tocainide; Ventricular Fibrillation | 1984 |
1 trial(s) available for encainide and Coronary Disease
| Article | Year |
|---|---|
Treatment of frequent ventricular arrhythmia with encainide: assessment using serial ambulatory electrocardiograms, intracardiac electrophysiologic studies, treadmill exercise tests, and radionuclide cineangiographic studies.
Topics: Adult; Aged; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Coronary Disease; Electrocardiography; Encainide; Exercise Test; Female; Heart Ventricles; Hemodynamics; Humans; Male; Middle Aged; Radionuclide Imaging | 1982 |
5 other study(ies) available for encainide and Coronary Disease
| Article | Year |
|---|---|
Electrophysiologic effects of encainide on acutely ischemic rabbit myocardial cells.
Topics: Action Potentials; Anilides; Animals; Anti-Arrhythmia Agents; Coronary Disease; Encainide; Heart; Rabbits; Refractory Period, Electrophysiological | 1982 |
Impact of the Food and Drug Administration approval of flecainide and encainide on coronary artery disease mortality: putting "Deadly Medicine" to the test.
Topics: Anti-Arrhythmia Agents; Coronary Disease; Drug Approval; Drug Utilization; Encainide; Evaluation Studies as Topic; Flecainide; Humans; Linear Models; Practice Patterns, Physicians'; Survival Analysis; United States; United States Food and Drug Administration; Ventricular Premature Complexes | 1997 |
Electrophysiologic and electrocardiographic effects, efficacy and safety of encainide in malignant ventricular arrhythmias associated with coronary artery disease.
Topics: Aged; Aged, 80 and over; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Disease; Electrocardiography; Electrophysiology; Encainide; Female; Follow-Up Studies; Humans; Male; Middle Aged; Recurrence | 1990 |
Selective depression of maximum rate of depolarization of guinea-pig ventricular action potentials by amiodarone and lignocaine in simulated ischaemia: comparison with encainide.
Topics: Action Potentials; Amiodarone; Anilides; Animals; Anti-Arrhythmia Agents; Coronary Disease; Encainide; Guinea Pigs; Heart; Heart Ventricles; Kinetics; Lidocaine; Myocardium; Sodium Channels; Stimulation, Chemical | 1990 |
Clinical predictors of arrhythmia worsening by antiarrhythmic drugs.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Disease; Electrocardiography; Encainide; Female; Heart Ventricles; Humans; Male; Mexiletine; Middle Aged; Quinidine; Retrospective Studies | 1988 |